MedPath

Cardiofocus, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:0
Completed:6

Trial Phases

4 Phases

Phase 2:1
Phase 3:3
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (40.0%)
Phase 3
3 (30.0%)
Phase 4
2 (20.0%)
Phase 2
1 (10.0%)

Pulmonary Vein Isolation with the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF

Not Applicable
Recruiting
Conditions
Atrial Fibrillation (Paroxysmal)
First Posted Date
2025-02-17
Last Posted Date
2025-02-17
Lead Sponsor
CardioFocus
Target Recruit Count
50
Registration Number
NCT06828939
Locations
🇨🇿

Na Homolce Hospital, Prague, Czech Republic

HeartLight X3 Endoscopic Ablation System With Excalibur Balloon for Treatment of Symptomatic Persistent AF

Not Applicable
Completed
Conditions
Atrial Fibrillation
First Posted Date
2019-06-17
Last Posted Date
2021-07-20
Lead Sponsor
CardioFocus
Target Recruit Count
11
Registration Number
NCT03988244
Locations
🇨🇿

Nemocnice Na Homolce, Prague, Czechia

Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon

Not Applicable
Completed
Conditions
Atrial Fibrillation
First Posted Date
2018-03-20
Last Posted Date
2021-02-08
Lead Sponsor
CardioFocus
Target Recruit Count
60
Registration Number
NCT03470636
Locations
🇨🇿

Nemocnice Na Homolce, Prague, Czechia

CardioFocus HeartLight Post-Approval Study

Not Applicable
Recruiting
Conditions
Atrial Fibrillation
First Posted Date
2017-05-30
Last Posted Date
2024-08-20
Lead Sponsor
CardioFocus
Target Recruit Count
250
Registration Number
NCT03168659
Locations
🇺🇸

University of Arizona Sarver HeartCenter, Tucson, Arizona, United States

🇺🇸

University of Illinois, Chicago, Illinois, United States

🇺🇸

Mount Sinai Hospital, New York, New York, United States

and more 1 locations

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Phase 3
Completed
Conditions
Paroxysmal Atrial Fibrillation
First Posted Date
2011-10-20
Last Posted Date
2016-09-08
Lead Sponsor
CardioFocus
Target Recruit Count
405
Registration Number
NCT01456000
Locations
🇺🇸

University of Alabama, Birmingham, Birminham, Alabama, United States

🇺🇸

Stanford Hospital, Palo Alto, California, United States

🇺🇸

Regional Cardiology Associates, Mercy General Hospital, Sacramento, California, United States

and more 18 locations
  • Prev
  • 1
  • 2
  • Next

News

CardioFocus Initiates Clinical Trial of OptiShot Pulsed Field Ablation System for Atrial Fibrillation

CardioFocus has commenced a clinical trial (VISION AF) evaluating the OptiShot Pulsed Field Ablation (PFA) System for paroxysmal atrial fibrillation treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.